Bristol-Myers Squibb Aktie
53,90USD | -2,06USD | -3,68% |
WKN: 850501 / ISIN: US1101221083
Personal
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 30 250 | 32 200 | 34 300 | 34 100 | 34 100 |
Umsatz pro Mitarbeiter in Mio. EUR | 1,41 | 1,44 | 1,35 | 1,32 | 1,42 |
Bilanz (in Mio. USD) - Aktiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 30 192 | 33 262 | 27 273 | 31 770 | 29 780 |
Summe Anlagevermögen | 88 289 | 76 052 | 69 547 | 63 389 | 62 823 |
Summe Aktiva | 118 481 | 109 314 | 96 820 | 95 159 | 92 603 |
Bilanz (in Mio. USD) - Passiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Fremdkapital | 80 599 | 73 308 | 65 702 | 65 674 | 76 215 |
Summe Eigenkapital | 37 882 | 36 006 | 31 118 | 29 485 | 16 388 |
Summe Passiva | 118 481 | 109 314 | 96 820 | 95 159 | 92 603 |
Adresse
Route 206 & Province Line Road, 08543 Princeton | |
Telefon | +1 (609) 252-4621 |
Internet | http://www.bms.com |
Management
Abed Al-Nasser Odeh
Manager |
Adam Lenkowsky
Chief Commercialization Officer & Executive VP |
Amanda Poole
Chief Human Resources Officer & Executive VP |
Amy Fallone
Secretary |
Cari Gallman
Executive Vice President-Corporate Affairs |
Catalina Vargas
Chief Of Staff |
Christopher S. Boerner
Chairman & Chief Executive Officer |
David V. Elkins
Chief Financial Officer & Executive Vice President |
Deepak L. Bhatt
Independent Director |
Derica W. Rice
Independent Director |
Estelle Vester-Blokland
Senior VP-Global Medical Affairs |
Frank Incontrera
Director-Global Energy Services |
Greg Meyers
Chief Digital & Technology Officer |
Julia A. Haller
Independent Director |
Karen H. Vousden
Independent Director |
Kimberly McCutcheon Jablonski
Chief Compliance & Ethics Officer |
Manuel Hidalgo Medina
Independent Director |
Maria V. Lopez Bresnahan
Vice President |
Mark Rolfe
Senior Vice President |
Michael R. McMullen
Independent Director |
Paula A. Price
Independent Director |
Peter J. Arduini
Independent Director |
Phil Holzer
Chief Accounting Officer, Senior VP & Controller |
Phyllis R. Yale
Independent Director |
Robert M. Plenge
Chief Research Officer, Head-Research & EVP |
Samit Hirawat
Chief Medical Officer & EVP-Drug Development |
Sandra Leung
Executive Vice President & General Counsel |
Teresa M. Foy
Senior VP-Immuno Oncology & Cell Therapy |
Theodore Rapp Samuels
Lead Independent Director |
William Perhacs
Director-Global Energy & Sustainability Services |